Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1999;94:71-77
© 1999 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MATSUMOTO, Y.
Right arrow Articles by SUGIMORI, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MATSUMOTO, Y.
Right arrow Articles by SUGIMORI, H.

ORIGINAL RESEARCH

Apoptosis and Ki-67 Expression in Adenomyotic Lesions and in the Corresponding Eutopic Endometrium

YUMI MATSUMOTO, MD, TSUYOSHI IWASAKA, MD, PhD, FUMIO YAMASAKI, MD, PhD and HAJIME SUGIMORI, MD, PhD

From the Department of Obstetrics and Gynecology, Saga Medical School, Saga, Japan.

Address reprint requests to: Tsuyoshi Iwasaka, MD, PhD, Department of Obstetrics and Gynecology, Saga Medical School, 1-1, Nabeshima 5-chome, 849-8501 Saga, Japan

Objective: To examine biologic and proliferative properties of adenomyotic lesions and to determine whether adenomyotic lesions originate in the basal layer of the eutopic endometrium.

Methods: We examined eutopic and ectopic endometria from 23 patients with adenomyosis. To obtain evidence for the induction of programmed cell death, apoptotic cells were identified using a modified terminal deoxynucleotidyltransferase-biotin nick end-labeling method. To evaluate cell death repressor activity, bcl-2 gene expression was examined using immunohistochemical staining. As a proliferative marker, Ki-67 expression was also examined immunohistochemically.

Results: In the eutopic endometrium, apoptosis was most frequently observed in epithelial cells during mid- to late secretory phases, although it was rarely found during early proliferative through early secretory phases (P < .01). In contrast, bcl-2 gene expression inversely correlated with the appearance of apoptosis. A similar tendency was observed in stromal cells. In the ectopic endometrium of adenomyosis, endometrial dating revealed that secretory change was rare, even in the secretory phase, and that induction of apoptotic cells as well as bcl-2 gene expression showed no cyclic change. In stromal cells of the ectopic endometrium, apoptosis was more frequent than was seen in the eutopic endometrium, in all menstrual phases (P < .05). Ki-67 was constantly expressed in the glandular epithelium of the ectopic endometrium, irrespective of the menstrual phases, whereas in the secretory phase it was less expressed in the eutopic endometrium of functional and basal layers (P < .01).

Conclusion: The induction of apoptosis seems to be regulated by hormonal changes in the eutopic endometrium and has an inverse correlation with bcl-2 gene expression. The ectopic endometrium in adenomyosis is rarely influenced by hormonal change and has different biologic and proliferative properties than events observed in the eutopic endometrium findings, which strongly suggest that the adenomyotic lesion does not originate in the basal endometrium.




This article has been cited by other articles:


Home page
Hum ReprodHome page
J.-H. Yang, M.-Y. Wu, C.-D. Chen, M.-J. Chen, Y.-S. Yang, and H.-N. Ho
Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis
Hum. Reprod., April 1, 2007; 22(4): 945 - 952.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
A. G. Goumenou, I. M. Matalliotakis, M. Tzardi, Y. G. Fragouli, N. G. Mahutte, and A. Arici
Apoptosis and Differential Expression of Apoptosis-Related Proteins in Endometriotic Glandular and Stromal Cells
Reproductive Sciences, July 1, 2004; 11(5): 318 - 322.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Ueda, Y. Yamashita, M. Takehara, Y. Terai, K. Kumagai, K. Ueki, K. Kanda, H. Yamaguchi, D. Akise, Y.-C. Hung, et al.
Survivin Gene Expression in Endometriosis
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3452 - 3459.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. E. Hale, C. L. Hughes, and J. M. Cline
Endometrial Cancer: Hormonal Factors, the Perimenopausal ""Window of Risk,"" and Isoflavones
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 3 - 15.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Maruo, J.B. Laoag-Fernandez, P. Pakarinen, H. Murakoshi, I.M. Spitz, and E. Johansson
Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium
Hum. Reprod., October 1, 2001; 16(10): 2103 - 2108.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
W.P. Dmowski, J. Ding, J. Shen, N. Rana, B.B. Fernandez, and D.P. Braun
Apoptosis in endometrial glandular and stromal cells in women with and without endometriosis
Hum. Reprod., September 1, 2001; 16(9): 1802 - 1808.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Obstetricians and Gynecologists.